Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Vistagen Therapeutics (VTGN) Other Gross PP&E Adjustments (2017 - 2025)

Vistagen Therapeutics' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$939000.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 35.73% year-over-year to -$939000.0; the TTM value through Dec 2025 reached -$939000.0, up 35.73%, while the annual FY2025 figure was -$2.5 million, 19.3% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$939000.0 at Vistagen Therapeutics, up from -$1.1 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.7 million in Q2 2021 and bottomed at -$3.1 million in Q1 2024.
  • The 4-year median for Other Gross PP&E Adjustments is -$1.6 million (2024), against an average of -$1.4 million.
  • The largest YoY upside for Other Gross PP&E Adjustments was 167.88% in 2021 against a maximum downside of 228.74% in 2021.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$1.2 million in 2021, then tumbled by 67.65% to -$1.9 million in 2023, then rose by 24.44% to -$1.5 million in 2024, then surged by 35.73% to -$939000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTGN's Other Gross PP&E Adjustments are -$939000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$1.2 million (Q2 2025).